Fitzgerald Thomas A 4
4 · Transcode Therapeutics, Inc. · Filed Oct 2, 2023
Insider Transaction Report
Form 4
Fitzgerald Thomas A
DirectorVP, Chief Financial Officer
Transactions
- Purchase
Common Stock
2023-09-28$0.51/sh+49,350$25,169→ 56,318 total
Footnotes (2)
- [F1]Represents shares acquired pursuant to an underwritten public offering of common stock by the Issuer.
- [F2]Reported amount reflects a 1-for-20 reverse stock split of the Issuer's common stock, which became effective as of May 22, 2023.